Human TWEAK R/TNFRSF12 Antibody Summary
Glu28-Trp79
Accession # Q9NP84.1
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TWEAK R/TNFRSF12
The gene for TNF-related weak inducer of apoptosis receptor (TWEAK R) was originally identified as a fibroblast growth factor-inducible immediate-early response gene Fn14 in mouse NIH 3T3 fibroblasts (1, 2). Human TWEAK R cDNA encodes a 129 amino acid (aa) residue type I transmembrane protein with a 27 aa signal peptide, a 53 aa extracellular domain, a 21 aa transmembrane domain and a 28 aa cytoplasmic domain (1-3). Human and mouse TWEAK R share 82% aa sequence identity. TWEAK R is the smallest member of the TNF receptor superfamily and contains only one cysteine-rich region in its extracellular domain. The TWEAK R cytoplasmic domain conatins one TRAF binding motif which binds TRAFs 1, 2, and 3. TWEAK R binds its ligand TWEAK/TNFSF12 with high affinity to initiate a signal transduction cascade that depending upon the cell type, may lead to a variety of cellular responses including cell death, cell proliferation, and angiogenesis (2-6). In new born mice, TWEAK R is highly expressed in all tissues examined (heart, intestine, kidney, liver, lung and skin) (1). In adult mice, high TWEAK R expression levels are found in the heart and ovary, while lower expression levels are detected in the lung, kidney, skin. Elevated levels of TWEAK R mRNA were found in human or mouse hepatocellular carcinoma specimens, in regenerating mouse liver and in injured rat arteries (2, 3).
- Meighan-Mantha, R. et al. (1999) J. Biol. Chem. 274:33166.
- Feng, S. et al. (2000) Am J. Pathol. 156:1253.
- Wiley, S. et al. (2001) Immunity 15:837.
- Schneider, P. et al. (1999) Eur. J. Immunol. 29:1785.
- Nakayama, M. et al. (2002) J. Immunol. 168:734.
- Lynch, C.N. et al. (1999) J. Biol. Chem. 274:8455.
Product Datasheets
Citations for Human TWEAK R/TNFRSF12 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
Transcriptomic analysis reveals cell apoptotic signature modified by heparanase in melanoma cells
Authors: T Song, D Spillmann
J. Cell. Mol. Med., 2019-05-02;0(0):.
-
A Homogeneous HTRF Assay for the Identification of Inhibitors of the TWEAK-Fn14 Protein Interaction
Authors: Tiziana Benicchi, Sara Iozzi, Andreas Svahn, Hanna Axelsson, Elisa Mori, Simonetta Bernocco et al.
J Biomol Screen
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human TWEAK R/TNFRSF12 Antibody
There are currently no reviews for this product. Be the first to review Human TWEAK R/TNFRSF12 Antibody and earn rewards!
Have you used Human TWEAK R/TNFRSF12 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image